Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Nov 30, 2020 1:28pm
57 Views
Post# 32001514

RE:RE:RE:ISRAEL

RE:RE:RE:ISRAELThe USAMRIID test is important. It is imperative to get it done since Corvax will be subjected to a genetically modified mice that is expressing the ACE2 receptor, mimicking how human cells would react to covid. The Tel Aviv test of  Dr., Haggin, just measured and confirmed that Corvax can generate antibody and stimulate T- Cells.  The USAMRIID test wil confirm if the antibody and T-Cells are specific and can counter active Covid-19 viruses. This is the closest one to a human test, after this its smooth sailing to phase 1 and 2. You might ask how come Moderna did not have this kind of test, it is because this lethal mice test for covid was just invented by USAMRIID back in August, when Moderna was already already in early stage of phase 3. Corvax is being subjected to a more stringent battery of test compared to the early ones, like Moderna.

Charleyfarley wrote:
The Us Army (USAMRIID) took precedence. Quite rightly so if you know your Politics


<< Previous
Bullboard Posts
Next >>